Pathogenic variants in HGF give rise to childhood-to-late onset primary lymphoedema by loss of function
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Murat Alpaslan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Human Molecular Genetics, de Duve Institute, University of Louvain, Avenue Hippocrate 74, Brussels 1200, Belgium. Hauptthemen laut MEDLINE: Hepatocyte Growth Factor, Lymphedema. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Lottery, Belgium and the Foundation against Cancer, Genomics Platform of UCLouvain and de Duve Institute, Fonds De La Recherche Scientifique - FNRS.
Abstract (Originalsprache)
Developmental and functional defects in the lymphatic system are responsible for primary lymphoedema (PL). PL is a chronic debilitating disease caused by increased accumulation of interstitial fluid, predisposing to inflammation, infections and fibrosis. There is no cure, only symptomatic treatment is available. Thirty-two genes or loci have been linked to PL, and another 22 are suggested, including Hepatocyte Growth Factor (HGF). We searched for HGF variants in 770 index patients from the Brussels PL cohort. We identified ten variants predicted to cause HGF loss-of-function (six nonsense, two frameshifts, and two splice-site changes; 1.3% of our cohort), and 14 missense variants predicted to be pathogenic in 17 families (2.21%). We studied co-segregation within families, mRNA stability for non-sense variants, and in vitro functional effects of the missense variants. Analyses of the mRNA of patient cells revealed degradation of the nonsense mutant allele. Reduced protein secretion was detected for nine of the 14 missense variants expressed in COS-7 cells. Stimulation of lymphatic endothelial cells with these 14 HGF variant proteins resulted in decreased activation of the downstream targets AKT and ERK1/2 for three of them. Clinically, HGF-associated PL was diverse, but predominantly bilateral in the lower limbs with onset varying from early childhood to adulthood. Finally, aggregation study in a second independent cohort underscored that rare likely pathogenic variants in HGF explain about 2% of PL. Therefore, HGF signalling seems crucial for lymphatic development and/or maintenance in human beings and HGF should be included in diagnostic genetic screens for PL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Human Molecular Genetics, de Duve Institute, University of Louvain, Avenue Hippocrate 74, Brussels 1200, Belgium.
- Department of vascular medicine, Hospital Saint-Eloi, University Hospital of Montpellier, Avenue Augustin Fliche 80, Montpellier 34090, France.
- Leiden University Medical Center, Albinusdreef 2, Leiden 2333, the Netherlands.
- Clinica Alemana Universidad del Desarrollo, Av Plaza 680, Las Condes, Lo Barnechea, Región Metropolitana 7710167, Chile.
- Clinical Sciences, Research Group Reproduction and Genetics, Centre for Medical Genetics, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, Brussels 1090, Belgium.
- Center for Vascular Anomalies, Division of Plastic Surgery, Cliniques Universitaires Saint-Luc, University of Louvain, Avenue Hippocrate 10, Brussels 1200, Belgium.
ORCID-Profile: Murat Alpaslan, Elodie Fastré, Sandrine Mestre, Arie van Haeringen, Gabriela M Repetto, Kathelijn Keymolen, Laurence M Boon, Florence Belva, Guido Giacalone, Nicole Revencu, Yves Sznajer, Vaughan Keeley, Sahar Mansour, Kristiana Gordon, Silvia Martin-Almedina, Sara Dobbins, Pia Ostergaard, Isabelle Quere, Pascal Brouillard, Miikka Vikkula
Förderung
- National Lottery, Belgium and the Foundation against Cancer
- Genomics Platform of UCLouvain and de Duve Institute
- Fonds De La Recherche Scientifique - FNRS
- la Région wallonne dans le cadre du financement de l'axe stratégique FRFS-WELBIO
- Fonds de la Recherche Scientifique
- King Baudouin Foundation
- Marie Skłodowska-Curie
- Leducq Foundation Networks of Excellence Program
Zitieren
APA
Alpaslan, M., Fastré, E., Mestre, S., van Haeringen, A., Repetto, G. M., Keymolen, K., Boon, L. M., Belva, F., Giacalone, G., Revencu, N., Sznajer, Y., Riches, K., Keeley, V., Mansour, S., Gordon, K., Martin-Almedina, S., Dobbins, S., Ostergaard, P., Quere, I., …, & Vikkula, M. (2024). Pathogenic variants in HGF give rise to childhood-to-late onset primary lymphoedema by loss of function. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae060
Vancouver
Alpaslan M, Fastré E, Mestre S, van Haeringen A, Repetto GM, Keymolen K, et al. Pathogenic variants in HGF give rise to childhood-to-late onset primary lymphoedema by loss of function. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae060
BibTeX
@article{Alpaslan2024,
author = {Alpaslan, Murat and Fastré, Elodie and Mestre, Sandrine and van Haeringen, Arie and Repetto, Gabriela M and Keymolen, Kathelijn and Boon, Laurence M and Belva, Florence and Giacalone, Guido and Revencu, Nicole and Sznajer, Yves and Riches, Katie and Keeley, Vaughan and Mansour, Sahar and Gordon, Kristiana and Martin-Almedina, Silvia and Dobbins, Sara and Ostergaard, Pia and Quere, Isabelle and Brouillard, Pascal and Vikkula, Miikka},
title = {Pathogenic variants in HGF give rise to childhood-to-late onset primary lymphoedema by loss of function},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae060}
}
EUVIMED